SecBot SecBot
8-K ·Filed Jul 10, 2026

HSCS

HeartSciences Inc.
NEUTRAL
Impact 4/10
Horizonmonths Processed3mo ago SEC0001213900-26-077218
Actionable Insight • Neutral

Monitor for shareholder vote on the Fortitude Mining reverse merger — the CFO retention package closes only if the merger closes. If the merger stalls or is voted down, the RSUs and enhanced severance disappear entirely. No separate trading signal from this compensatory filing alone.

DirectionNeutral
Confidencemedium
Horizonmonths
Final — all horizons settled through T+60d ⚠ clustered
HSCS ▲ +42.80% at T+60d
NEUTRAL call +42.80% · α vs SPY +38.81% · entry $2.64 → $3.77
Entry = T+0 close
Jul 10, 2026
via day close
T+1d
-0.76%
call -0.76% · α -1.11%
$2.62
settled 4mo ago
T+5d
+1.89%
call +1.89% · α +2.68%
$2.69
settled 3mo ago
T+20d
-21.59%
call -21.59% · α -24.78%
$2.07
settled 3mo ago
T+60d
+42.80%
call +42.80% · α +38.81%
$3.77
settled 21d ago

Price Chart

Loading chart...

Executive Summary

HeartSciences amended CFO Danielle Watson's employment agreement and granted 25,000 RSUs, both contingent on the closing of its pending reverse merger with Fortitude Mining Holdings. The amendment provides six months' base salary severance, COBRA coverage, and accelerated equity vesting upon qualifying termination. The RSUs vest quarterly over one year after closing, serving as retention compensation for the CFO through the merger.

Key Facts

  • CFO Danielle Watson received amended employment agreement with severance: six months base salary lump sum, COBRA for six months, and 100% acceleration of pre-Closing equity awards
  • Watson was granted 25,000 RSUs under the 2023 Equity Incentive Plan, vesting quarterly over one year after merger closing
  • RSUs and amendment automatically void if merger does not close
  • A discretionary performance bonus (cash and/or equity) was introduced, determined annually by the Board
  • Amendment and RSUs were executed July 7, 2026, reported via 8-K filed July 10, 2026

Financial Impact

25,000 RSUs granted with no dollar value disclosed; severance equals six months of CFO's base salary (not quantified)

dilutionexecutive compensation

Risk Factors

  • Merger may fail to obtain shareholder approval or regulatory clearance, voiding the Watson amendment and RSU grant
  • Post-merger dilution from RSUs (25,000 shares) is modest but unquantifiable without current share price
  • Company is transforming from a medical device firm to a cryptocurrency mining entity — fundamental risk for existing HSCS shareholders

Market Snapshot

Exchange
Nasdaq
Sector
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Analyst Consensus
88% bullish (8 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 7 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (HSCS) — Batch item 10001213900-26-077218
Document: ea0297481-8k_heartsci.htm0001213900-26-077218
Document: ea029748101ex10-1.htm0001213900-26-077218
Document: 0001213900-26-077218-index-headers.html0001213900-26-077218
Document: 0001213900-26-077218-index.html0001213900-26-077218
Document: 0001213900-26-077218.txt0001213900-26-077218
8-K Filing (HSCS) — Batch item 70001213900-26-077218
50 reports for HSCS
Performance horizon
71% Hit rate @ T+1 5 of 7 directional calls Went positive at some point 6 of 7 best @ T+20▲ +92.83%Aug 20, 2026
Filters
Rows
Reports for HSCS — sortable, filterable
TypeNow
Oct 26, 2026
today
DEFA14A
NEUTRAL ★ 4/10
—awaiting T+1——
Oct 23, 2026
2d ago
SC 13D/A
NEUTRAL ★ 3/10
$3.41awaiting T+1—$3.18 (−6.74%)
Oct 21, 2026
5d ago
DEFA14A
NEUTRAL ★ 5/10
$3.17 $3.14▼ −0.95%▼ −0.42%$3.18 (+0.32%)
Oct 19, 2026
7d ago
DEFA14A
NEUTRAL ★ 3/10
$3.13 $3.56▲ +13.74%▲ +13.21%$3.18 (+1.60%)
Oct 19, 2026
7d ago
DEFA14A
NEUTRAL ★ 3/10
$3.07 $3.13▲ +1.95%▲ +1.62%$3.18 (+3.58%)
Oct 19, 2026
7d ago
DEFM14A
BEARISH ★ 7/10
$3.07 $3.13▼ −1.95%▼ −1.62%$3.18 (−3.58%)
Oct 15, 2026
10d ago
DEFA14A
NEUTRAL ★ 4/10
$3.02 $3.07▲ +1.66%▲ +1.23%$3.18 (+5.30%)
Oct 9, 2026
16d ago
424B5
BEARISH ★ 5/10
$3.30 $3.09▲ +6.36%▲ +6.35%$3.18 (+3.64%)
Oct 6, 2026
20d ago
DEFA14A
MIXED ★ 5/10
$3.49 $3.04▼ −12.89%▼ −12.47%$3.18 (−8.88%)
Oct 6, 2026
20d ago
8-K
NEUTRAL ★ 4/10
$3.49 $3.04▼ −12.89%▼ −12.47%$3.18 (−8.88%)
Showing 10 of 50

US Market Status

Market Closed — Opens Tue (16h 37m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jul 10, 2026